查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球人工視網膜市場 2023-2030
市場調查報告書
商品編碼
1380452

全球人工視網膜市場 2023-2030

Global Artificial Retina Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 105 Pages | 商品交期: 2-3個工作天內

價格

預計全球人工視網膜市場在預測期（2023-2030年）將以8.1%的CAGR成長。人工視網膜市場的成長可歸因於老年黃斑部病變和色素性視網膜炎等視網膜疾病的日益流行，以及對先進眼科治療的需求不斷成長。此外，人工視網膜設備的技術進步、醫療保健支出的增加以及患者對這些設備可用性的認知不斷提高，預計將在未來幾年推動市場成長。根據世界衛生組織 (WHO) 的數據，全球至少有 22 億人有近距離視力或遠端視力障礙。其中至少有 10 億人的視力障礙本來可以預防或尚未解決。在全球範圍內，視力障礙和失明的主要原因是屈光不正和白內障。

細分市場前景

全球人工視網膜市場按類型和最終用戶進行細分。根據類型，市場分為視網膜前植入物、視網膜下植入物和神經外植入物。根據最終用戶，市場細分為醫院、診所和研究機構。其中，視網膜前植入物由於其更好的安全特性，預計將佔據相當大的市場佔有率。它可以透過比視網膜下植入物更小的切口進行植入和移除。這降低了併發症的風險，並且在必要時更容易更換植入物。

預計研究機構細分市場將在全球人工視網膜市場中佔據相當大的佔有率

在最終用戶中，研究機構細分市場預計將在全球人工視網膜市場中佔據相當大的佔有率。此細分市場的成長歸因於對更好和先進治療的需求不斷增加，因此公司和研究機構更加關注更好和改進設備的研究和試驗。例如，2020年6月，由香港科技大學（科大）科學家領導的國際團隊最近研發了全球首個3D人工眼，其性能優於現有的仿生眼，在某些情況下甚至超過了現有的仿生眼。為人形機器人帶來視覺，為視力障礙患者帶來新的希望。

區域展望

全球人工視網膜市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本） 、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於經濟發展以及英國、德國等國家政府支持的不斷增加，預計歐洲將在全球市場中佔有顯著佔有率。例如，2022 年 1 月，仿生眼植入物使英國盲人婦女能夠檢測到視覺訊號。這位來自達格納姆的婦女患有地圖狀萎縮症。這種情況是乾性老年黃斑部病變 (AMD) 最常見的形式，影響著全世界數百萬人，並可能導致失明。

北美地區預計全球人工視網膜市場CAGR顯著成長

在所有地區中，北美地區預計在預測期內將以相當大的CAGR成長。區域成長歸因於強大的醫療基礎設施和醫療產業研發的高支出。例如，2020 年1 月，匹茲堡大學醫學中心(UPMC) 為美國第一位患者植入了新型無線視網膜設備，這是一項臨床試驗的一部分，旨在恢復晚期老年黃斑部病變(AMD) 患者的部分視力），一種導致永久性失明的疾病。除此之外，這些地區的主要老牌公司推出的產品正在穩步增加，進一步推動了該地區的醫療產業，進而推動了市場的成長。據美國國家醫學圖書館稱，Alpha AMS 視網膜下植入物改善了 6 名參與者中 5 名的視覺表現，並表現出長達 24 個月的持續功能。儘管植入手術仍然具有挑戰性，但光學相干斷層掃描 (OCT) 顯微鏡導引等新發展使手術技術得到了改進。

市場參與者展望

服務全球人工視網膜市場的主要公司包括： Altris, Inc.、Axorus、Bionic Vision Technologies、Intelligent Implants, Ltd.、Labtician Ophthalmics, Inc.、LambdaVision, Inc.、Medtronic、Nano Retina 等。市場參與者透過各種策略（包括併購、合作、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2023年4月，RetinAI和勃林格殷格翰聯手利用人工智慧（AI）推動地圖狀萎縮的辨識和治療。這種合作關係有可能透過更精確地根據每個患者的具體情況量身定做治療來徹底改變治療方法。最終，這項合作旨在改變受視網膜疾病影響的個人的生活。

報告涵蓋：

  • 2022年市場價​​值資料分析及2030年預測。
  • 每個細分市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 在全球人工視網膜市場營運的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵細分市場來分析業務策略。
  • 市場進入和市場擴張策略分析。
  • 透過識別市場中「誰的立場」來制定競爭策略。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Aetna Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Bionic Vision Technologies
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Pixium Vision
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按產品類型分類的全球人工視網膜市場
    • 視網膜前植入物
    • 視網膜下植入物
    • 神經外植入物
  • 以最終用戶分類的全球人工視網膜市場
    • 醫院
    • 診所
    • 研究機構

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Altris, Inc.
  • Axorus
  • Bionic Vision Technologies
  • Intelligent Implants, Ltd.
  • Labtician Ophthalmics, Inc.
  • LambdaVision, Inc.
  • Medtronic
  • Nano Retina
  • Nidek Co. Ltd.
  • Optobionics
  • Retina Implant AG
  • Vivani Medical Inc.
Product Code: OMR2027759

Title: Global Artificial Retina Market Size, Share & Trends Analysis Report by Type (Epiretinal Implants, Subretinal Implants, and Epineural implants), and by End User (Hospital, Clinics, and Research institutes)Forecast Period (2023-2030).

The global artificial retina market is anticipated to grow at a CAGR of 8.1% during the Forecast Period (2023-2030). The growth of the artificial retina market can be attributed to the increasing prevalence of retinal diseases such as age-related macular degeneration and retinitis pigmentosa, along with the growing demand for advanced ophthalmic treatments. Additionally, technological advancements in artificial retina devices, increasing healthcare expenditure, and rising awareness among patients about the availability of these devices are expected to drive market growth in the coming years. According to World Health Organization (WHO), globally, at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion of these, vision impairment could have been prevented or is yet to be addressed. The leading causes of vision impairment and blindness at a global level are refractive errors and cataracts.

Segmental Outlook

The global artificial retina market is segmented on the type and end user. Based on the type, the market is sub-segmented into epiretinal Implants, subretinal Implants and epineural implants. And Based on the end user, the market is sub-segmented into hospital, clinics, and research institutes. Among the type, the Epiretinal Implants sub-segment is anticipated to hold a considerable share of the market, Owing to it better and safety features. It can be implanted and removed through a smaller incision than subretinal implants. This reduces the risk of complications and makes it easier to replace the implant if necessary.

The Research Institutes Sub-Segment is Anticipated to Hold a Considerable Share of the Global Artificial Retina Market

Among the end user, the research institutes sub-segment is expected to hold a considerable share of the global artificial retina market. The segmental growth is attributed to the increasing demand for better and advanced treatment, hence the companies and research institutes are focusing more on research and trails of better and improved devices. For instance, in June 2020, an international team led by scientists at the Hong Kong University of Science and Technology (HKUST) has recently developed the world's first 3D artificial eye with capabilities better than existing bionic eyes and in some cases, even exceed those of the human eyes, bringing vision to humanoid robots and new hope to patients with visual impairment.

Regional Outlook

The global artificial retina market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the economic development coupled with the increasing government support in countries such as UK, Germany, and others. For instance, in January 2022, Bionic eye implant enables blind UK woman to detect visual signals. The woman from Dagenham suffers from geographic atrophy. The condition is the most common form of dry age-related macular degeneration (AMD), which affects millions of people worldwide and can cause loss of sight.

The North America Region is Expected to Grow at a Significant CAGR in the Global Artificial Retina Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to strong healthcare infrastructure and high expenditure in R&D in medical industry. For instance, in January 2020, University of Pittsburgh Medical Center (UPMC) implanted the first patient in the US with a new wireless retinal device as part of a clinical trial aimed at restoring partial sight to patients with advanced age-related macular degeneration (AMD), a disease that leads to permanent blindness. Apart from this, the regions is witnessing a steady increase in product launches by key established companies, further advancing medical sector in the region, in turn propelling the market growth. According to National Library of Medicine, the Alpha AMS subretinal implant improved visual performance in 5 of 6 participants and has exhibited ongoing function for up to 24 months. Although implantation surgery remains challenging, new developments such as optical coherence tomography (OCT) microscope guidance added refinements to the surgical technique.

Market Players Outlook

The major companies serving the global artificial retina market include: Altris, Inc., Axorus, Bionic Vision Technologies, Intelligent Implants, Ltd., Labtician Ophthalmics, Inc., LambdaVision, Inc., Medtronic, Nano Retina, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2023, RetinAI and Boehringer Ingelheim have joined forces to advance the identification and treatment of geographic atrophy using artificial intelligence (AI). This partnership holds the potential to revolutionize treatments by tailoring them more precisely to each patient's specific condition. Ultimately, this collaboration aims to transform the lives of individuals affected by retinal diseases.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global artificial retina market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Aetna Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bionic Vision Technologies
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Pixium Vision
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Artificial retina Market by Product Type
    • 4.1.1. Epiretinal Implants
    • 4.1.2. Subretinal Implants
    • 4.1.3. Epineural Implants
  • 4.2. Global Artificial retina Market by End User
    • 4.2.1. Hospital
    • 4.2.2. Clinics
    • 4.2.3. Research Institutes

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Altris, Inc.
  • 6.2. Axorus
  • 6.3. Bionic Vision Technologies
  • 6.4. Intelligent Implants, Ltd.
  • 6.5. Labtician Ophthalmics, Inc.
  • 6.6. LambdaVision, Inc.
  • 6.7. Medtronic
  • 6.8. Nano Retina
  • 6.9. Nidek Co. Ltd.
  • 6.10. Optobionics
  • 6.11. Retina Implant AG
  • 6.12. Vivani Medical Inc.

LIST OF TABLES

  • 1. GLOBAL ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 2. GLOBAL EPIRETINAL IMPLANTS IN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL SUBRETINAL IMPLANTS IN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL EPINEURAL IMPLANTS IN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 6. GLOBAL ARTIFICIAL RETINA IN HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ARTIFICIAL RETINA IN CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL ARTIFICIAL RETINA IN RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 13. EUROPEAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. EUROPEAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 15. EUROPEAN ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 16. ASIA- PACIFIC ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. ASIA- PACIFIC ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 18. ASIA- PACIFIC ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD ARTIFICIAL RETINA MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ARTIFICIAL RETINA MARKET SHARE BY PRODUCT TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL EPIRETINAL IMPLANTS IN ARTIFICIAL RETINA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL SUBRETINAL IMPLANTS IN ARTIFICIAL RETINA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL EPINEURAL IMPLANTS IN ARTIFICIAL RETINA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL ARTIFICIAL RETINA MARKET SHARE BY END USER, 2022 VS 2030 (%)
  • 6. GLOBAL ARTIFICIAL RETINA IN HOSPITAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL ARTIFICIAL RETINA IN CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL ARTIFICIAL RETINA IN RESEARCH INSTITUTES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL ARTIFICIAL RETINA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. US ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. CANADA ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. UK ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. FRANCE ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. GERMANY ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. ITALY ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. SPAIN ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. REST OF EUROPE ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. INDIA ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CHINA ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. JAPAN ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SOUTH KOREA ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD ARTIFICIAL RETINA MARKET SIZE, 2022-2030 ($ MILLION)